Choose your City

Loading cities…

Women Cancer Screening Advanced

Women Cancer Screening Advanced is available for online booking with home sample collection.

Women Cancer Screening Advanced Info & Procedure

Group Name WELLNESS
Fasting See preparation details
Sample Type Blood (SEBL)
Sample Collection Home sample collection
Parameters 36 included
Laboratory Thyrocare

Tests included

36 parameters listed

Explore the tests in Women Cancer Screening Advanced by category.

Cancer Markers4
  • CA 15.3
  • CA 19.9
  • CA-125
  • CARCINO EMBRYONIC ANTIGEN (CEA)
Complete Hemogram28
  • BASOPHILS
  • BASOPHILS - ABSOLUTE COUNT
  • EOSINOPHILS
  • EOSINOPHILS - ABSOLUTE COUNT
  • HEMATOCRIT(PCV)
  • HEMOGLOBIN
  • IMMATURE GRANULOCYTE PERCENTAGE(IG%)
  • IMMATURE GRANULOCYTES(IG)
  • LYMPHOCYTE
  • LYMPHOCYTES - ABSOLUTE COUNT
  • MEAN CORP.HEMO.CONC(MCHC)
  • MEAN CORPUSCULAR HEMOGLOBIN(MCH)
  • MEAN CORPUSCULAR VOLUME(MCV)
  • MEAN PLATELET VOLUME(MPV)
  • MONOCYTES
  • MONOCYTES - ABSOLUTE COUNT
  • NEUTROPHILS
  • NEUTROPHILS - ABSOLUTE COUNT
  • NUCLEATED RED BLOOD CELLS
  • NUCLEATED RED BLOOD CELLS %
  • PLATELET COUNT
  • PLATELET DISTRIBUTION WIDTH(PDW)
  • PLATELET TO LARGE CELL RATIO(PLCR)
  • PLATELETCRIT(PCT)
  • RED CELL DISTRIBUTION WIDTH (RDW-CV)
  • RED CELL DISTRIBUTION WIDTH - SD(RDW-SD)
  • TOTAL LEUCOCYTES COUNT (WBC)
  • TOTAL RBC
Pregnancy1
  • ALPHA FETO PROTEIN
Pregnancy1
  • BETA HCG
Thyroid2
  • CALCITONIN
  • THYROGLOBULIN (TG)

Profile visual guide

Tap the guide to enlarge it and read every detail.

Women Cancer Screening Advanced visual guide
Visual guide
100%

Pinch with two fingers to zoom. Swipe to explore, or use + and −.

Women Cancer Screening Advanced visual guide

Women’s Marker Panel Reference Guide

  • This fasting profile reports 36 listed blood-test results.
  • It includes four selected tumour markers and a complete hemogram.
  • AFP, beta-hCG, calcitonin and thyroglobulin are also included.
  • These markers cannot screen for or diagnose cancer by themselves.

Why This Test Is Ordered

ReasonDescription
Know the exact profile scope
  • CA-125 is included within selected tumour markers.
  • CA 15.3, CA 19.9 and CEA are included.
  • AFP and beta-hCG are also listed.
  • Calcitonin and thyroglobulin complete the marker groups.
Understand marker limitations
  • Tumour markers are not reliable stand-alone screening tests.
  • A normal marker result cannot exclude cancer.
  • An elevated marker does not prove cancer.
  • Noncancerous conditions can affect marker results.
Plan appropriate follow-up
  • A clinician considers symptoms and personal history.
  • Family cancer history can change the evaluation plan.
  • Imaging or tissue testing may be needed.
  • Use prior reports only with matching laboratory context.

Symptoms And Who Should Test

SituationDescription
People with clinician-directed questions
  • Testing may follow a clinician’s specific concern.
  • Bring referral details when they are available.
  • Share personal and family cancer history.
  • Mention previous surgery, imaging or treatment.
People needing marker follow-up
  • Serial results can be useful in selected situations.
  • The clinician decides whether repeat testing is appropriate.
  • Trends should use comparable reports where possible.
  • Do not compare results without their reference intervals.
People with new concerning symptoms
  • Persistent bloating or pelvic pain needs clinical assessment.
  • Unexplained vaginal bleeding needs timely medical advice.
  • A new breast lump needs prompt examination.
  • Blood markers should not delay symptom evaluation.

Preparation And Interpretation Notes

TopicGuidance
Prepare for collection
  • Complete an overnight fast before sample collection.
  • The package uses serum and EDTA blood samples.
  • Confirm collection timing with the laboratory team.
  • Follow any clinician-specific medicine instructions.
Bring useful health information
  • Carry earlier reports when they are available.
  • List prescription medicines and supplements.
  • Mention current pregnancy or recent pregnancy changes.
  • Record symptoms, duration and relevant family history.
Use results safely
  • Do not treat a marker result as diagnosis.
  • Do not delay recommended imaging or examinations.
  • Discuss abnormal results with the ordering clinician.
  • Seek urgent care for severe or worsening symptoms.

Frequently Asked Questions

Does this profile diagnose cancer?

No; diagnosis requires clinical assessment and may need imaging or tissue testing.

Can it screen average-risk women for cancer?

No; these markers are not reliable stand-alone screening tests.

Does a normal result rule out cancer?

No; normal tumour-marker results cannot rule out cancer.

Does a high result prove cancer?

No; noncancerous conditions can raise some tumour markers.

Which tumour markers are included?

CA-125, CA 15.3, CA 19.9 and CEA are included.

Does it include a complete blood count?

Yes; the profile includes a complete hemogram.

Does it include thyroid-related markers?

Yes; calcitonin and thyroglobulin are included.

Is fasting required?

Yes; complete an overnight fast before collection.

Should symptoms wait for these results?

No; persistent or concerning symptoms need prompt clinical assessment.

Can I book this profile in {city}?

Collection in {city} depends on your address and serviceability.

Who can review results in {city}?

A clinician in {city} can review results with your history.

Why Choose Thyrocare for Women Cancer Screening Advanced

Get tested for Women Cancer Screening Advanced at fully automated diagnostic laboratory Thyrocare which has Centralized Processing Lab (CPL)
for esoteric tests and Regional Processing Labs in major cities of India.

Home Based Diagnostics

Home Based & Quality Diagnostics
at an Unbeatable Price


Carefully designed Panels to provide you with the most vital information for your health.

Convenient Home Based

Affordable — Book Online

Certified Labs — NABL, CAP, ISO

Graphical Reports Online

Laboratory technology

Thyrocare Technologies Limited has huge set up covering over 2 Lakh sq. ft. floor area ensures zero error processing if approx 50 thousand
specimens and over 3 lakh Clinical investigations per day is the right choice for your Women Cancer Screening Advanced testing.

Aptio™ Automation

Aptio Automation

Wellness

Similar tests & packages

Explore more options in this category.

Aarogyam A Pro - Package Aarogyam B Pro - Package Aarogyam C Pro Package Aarogyam C Pro With Heart Attack Risk Package Aarogyam D Pro Package Aarogyam E Pro Package Aarogyam F Pro Package Aarogyam Female Panel Aarogyam Lite Package Aarogyam Male Package Aarogyam Mini Aarogyam Stree - Package